0001203311-20-000132.txt : 20201123 0001203311-20-000132.hdr.sgml : 20201123 20201123201112 ACCESSION NUMBER: 0001203311-20-000132 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201119 FILED AS OF DATE: 20201123 DATE AS OF CHANGE: 20201123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRYSKA DAVID W CENTRAL INDEX KEY: 0001202335 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 201339558 MAIL ADDRESS: STREET 1: 749 N MARY AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-11-19 0 0001060736 Seagen Inc. SGEN 0001202335 GRYSKA DAVID W 21823 30TH DRIVE SE BOTHELL WA 98021 1 0 0 0 Common Stock 2020-11-19 4 M 0 7129 19.02 A 51977 D Common Stock 2020-11-19 4 S 0 7129 174.2 D 44848 D Common Stock 2020-11-19 4 M 0 7871 19.02 A 52719 D Common Stock 2020-11-19 4 S 0 7871 173.25 D 44848 D Non-Qualified Stock Option (right to buy) 19.02 2020-11-19 4 M 0 7129 0.0 D 2021-05-20 Common Stock 7129 7871 D Non-Qualified Stock Option (right to buy) 19.02 2020-11-19 4 M 0 7871 0.0 D 2021-05-20 Common Stock 7871 0 D Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Reflects sales of common stock executed in multiple transactions at prices ranging from $173.75 to $174.65. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $172.75 to $173.74 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Options were fully vested on 5/20/12. By: /s/ Jean Liu For: David W. Gryska 2020-11-23